
GLUCOWIZZARDTM Implantable Sensor is a revolutionary, miniaturized (0.5 x 0.5 x 5 mm) device that reads glucose levels and transmits the information to one of your personal accessory like cell phone, MP3 player PDA etc., More
Real time monitoring of various metabolites that control body’s function is important for improving the health of patients. The key for this is an implantable biosensor capable of autonomous yet continuous metabolite monitoring.More
Biorasis Inc. had the honor to be visited by Congressman Joe Courtney at February 24th. Congressman Joe Courtney toured Biorasis Inc. facility at the University of Connecticut Technology Incubation Program. Our CEO Dr. Ioannis Tomazos presented the company, its current developments and future outlook.
The National Science Foundation awarded Biorasis Inc. a Phase I SBIR grant to further its developments.
Biorasis's GlucowizzardTM and our Scientific Advisor Prof. Fotios Papadimitrakopoulos are featured in Popular Science magazine (March 2010). Please use the link below to go directly to the Popular Science article.
An Implantable Glucose Sensor Could Help Diabetics Stay Healthy
Biorasis Inc. in collaboration with the Yale Biotechnology and Pharmaceutical Society has developed an online Survey on Diabetes Management and Continuous Glucose Monitoring (CGM). Please take few minutes to complete the survey and help us understand better the requirements of an effective CGM system.
The following link will direct you to the survey. Survey
Thank you for your time and help!
Bioarsis Inc. has received a phase I SBIR grant from National Institute of Health which is aimed to commercialize its implantable biosensors platform.
Bioarsis Inc. receives the “The 2009 Connecticut’s Technology Council Company to Watch Award” for the second year in a row.